TPTX - Turning Point Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - TPTX (1595893)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
26 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2020-04-06
TPTXCui Jingrong JeanDirS - Sale$44.87-55,5002,027,889-3%-$2,490,476
2020-03-26
TPTXCui Jingrong JeanDirS - Sale$46.03-11,5002,083,389-1%-$529,372
M
2020-03-23
TPTXCui Jingrong JeanDirS - Sale$43.11-31,7922,094,889-1%-$1,370,451
M
2020-03-10
TPTXCui Jingrong JeanDirS - Sale$40.84-44,0002,126,681-2%-$1,796,843
M
2020-02-24
TPTXCui Jingrong JeanDirS - Sale$52.16-21,0002,170,681-1%-$1,095,422
2020-02-13
TPTXCui Jingrong JeanDirS - Sale$61.84-11,5002,082,517-1%-$711,137
M
2020-02-10
TPTXCui Jingrong JeanDirS - Sale$64.03-55,5002,094,017-3%-$3,553,744
M
2020-01-27
TPTXCui Jingrong JeanChief Scientific OfficerS - Sale$58.25-21,0002,149,517-1%-$1,223,284
2020-01-15
TPTXCui Jingrong JeanChief Scientific OfficerS - Sale$53.12-11,5002,170,517-1%-$610,853
M
2020-01-10
TPTXCui Jingrong JeanChief Scientific OfficerS - Sale$54.70-55,5002,182,017-2%-$3,036,046
M
2019-12-18
TPTXCui Jingrong JeanChief Scientific OfficerS - Sale$60.92-48,5002,237,517-2%-$2,954,577
M
2019-12-13
TPTXCui Jingrong JeanChief Scientific OfficerS - Sale$58.95-41,5002,286,017-2%-$2,446,620
M
2019-12-10
TPTXCui Jingrong JeanChief Scientific OfficerS - Sale$53.88-34,5001,026,219-3%-$1,858,709
M
2019-12-05
TPTXCui Jingrong JeanChief Scientific OfficerS - Sale$51.77-118,5002,362,017-5%-$6,134,753
2019-09-10
TPTXGlaxosmithkline PlcDirP - Purchase$45.00+177,7772,170,327+9%+$7,999,965
2019-09-10
TPTXGeorge SimeonDirP - Purchase$45.00+177,7772,170,327+9%+$7,999,965
2019-09-10
TPTXLarson YiEVP, CFOP - Purchase$45.00+2,2222,222New+$99,990
2019-09-10
TPTXCountouriotis AthenaPres, CEOP - Purchase$45.00+10,00022,000+83%+$450,000
D
2019-04-22
TPTXCormorant Asset Management, LP10%P - Purchase$18.00+400,0003,099,099+15%+$7,200,000
D
2019-04-22
TPTXGlaxosmithkline PlcDir, 10%P - Purchase$18.00+325,0001,992,550+19%+$5,850,000
D
2019-04-22
TPTXOrbimed Advisors LLCDirP - Purchase$18.00+360,0002,027,550+22%+$6,480,000
D
2019-04-22
TPTXLu HongboDirP - Purchase$18.00+60,0001,727,550+4%+$1,080,000
D
2019-04-22
TPTXGordon Carl LDirP - Purchase$18.00+360,0002,027,550+22%+$6,480,000
D
2019-04-22
TPTXGeorge SimeonDirP - Purchase$18.00+325,0001,992,550+19%+$5,850,000
2019-04-22
TPTXBaker Brian LeeVP of Finance, Admin.P - Purchase$18.00+2,8002,800New+$50,400
2019-04-22
TPTXCountouriotis AthenaPres, CEOP - Purchase$18.00+12,00012,000New+$216,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top